[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BioPharmCatalyst [@BPharmCatalyst](/creator/twitter/BPharmCatalyst) on x 29.8K followers Created: 2025-07-18 12:20:59 UTC $TELO reported promising data for Telomir-1, which showed it could reverse epigenetic gene silencing and restore tumor suppressors in human prostate cancer cells, outperforming chemotherapy and rapamycin. See More Pre-market Movers 👇 $MESO $CNSP $SRPT $WINT $IINN  XXXXX engagements  **Related Topics** [$iinn](/topic/$iinn) [$wint](/topic/$wint) [$srpt](/topic/$srpt) [$cnsp](/topic/$cnsp) [$meso](/topic/$meso) [$telo](/topic/$telo) [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/BPharmCatalyst/status/1946183417592152183)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioPharmCatalyst @BPharmCatalyst on x 29.8K followers
Created: 2025-07-18 12:20:59 UTC
$TELO reported promising data for Telomir-1, which showed it could reverse epigenetic gene silencing and restore tumor suppressors in human prostate cancer cells, outperforming chemotherapy and rapamycin.
See More Pre-market Movers 👇
$MESO $CNSP $SRPT $WINT $IINN
XXXXX engagements
Related Topics $iinn $wint $srpt $cnsp $meso $telo sarepta therapeutics inc stocks healthcare
/post/tweet::1946183417592152183